Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
33 hedge funds and large institutions have $95.5M invested in Renalytix plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 9 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
6% more funds holding
Funds holding: 31 → 33 (+2)
8% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $945K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $121M → $95.5M (-$25.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Slate Path Capital
New York
|
+$3.51M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.84M |
| 3 |
Lazard Asset Management
New York
|
+$1.3M |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$969K |
| 5 |
Two Sigma Investments
New York
|
+$959K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.74M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$3.38M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.98M |
| 4 |
FAM
Fred Alger Management
New York
|
-$2.03M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$742K |
RNLX Hedge Fund Activity: Q4 2021 in Review
33 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q4 2021, worth a combined $95.5M — down 21% from $121M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RNLX positions and 9 closed out — a net gain of 2 holders — while 12 added to existing stakes and 7 trimmed.
The largest buyer was Slate Path Capital, opening a new position worth an estimated $3.51M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $7.74M sold.
- 33 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q4 2021, up from 31 in Q3 2021.
- Funds reported $95.5M of Renalytix plc American Depositary Shares stock for Q4 2021, down 21% quarter-over-quarter.
- 11 funds opened new Renalytix plc American Depositary Shares positions in Q4 2021 and 9 closed out, a net change of +2 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q4 2021 was Slate Path Capital, an estimated $3.51M added.
- The largest Renalytix plc American Depositary Shares seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $7.74M sold.
Based on aggregated 13F filings for Q4 2021.